Unlock instant, AI-driven research and patent intelligence for your innovation.

Boc-L-valine pharmaceutical composition and application in biological pharmacy

A technology of boc-l- and valine, which is applied in the field of biomedicine and can solve problems that have not been reported yet

Inactive Publication Date: 2016-08-17
ZHENJIANG GAOHAI BIOLOGICAL PHARMA CO LTD
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] So far, there has been no report on the correlation between Boc-L-valine and its pharmaceutical composition and acute lung injury

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Boc-L-valine pharmaceutical composition and application in biological pharmacy
  • Boc-L-valine pharmaceutical composition and application in biological pharmacy
  • Boc-L-valine pharmaceutical composition and application in biological pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Compound (I) Separation Preparation and Structure Confirmation

[0019] Separation method: (a) crush the dried lily bulbs (2kg), extract with 90% ethanol under heat reflux (15L × 3 times), combine the extracts, concentrate until no alcohol smell (3L), and then use petroleum ether (3L× 3 times), ethyl acetate (3L × 3 times) and water-saturated n-butanol (3L × 3 times) were extracted to obtain petroleum ether extract, ethyl acetate extract and n-butanol extract respectively; (b) step (a) The ethyl acetate extract in (a) was removed with D101 type macroporous resin, first eluted with 35% ethanol for 8 column volumes, then with 90% ethanol for 12 column volumes, collected 90% eluent, and subtracted Concentrate under pressure to obtain the 90% ethanol elution concentrate; (c) 90% ethanol elution concentrate in step (b) is separated with normal phase silica gel, and the volume ratio is 120:1 (11 column volumes), 60:1 successively (9 column volumes), 30:1 (9 column...

Embodiment 2

[0022] Embodiment 2: pharmacological action

[0023] 1. Materials and methods

[0024] 1.1 Animals

[0025] Healthy male clean-grade SD rats with a body weight of 320-370 g (provided by the Animal Experiment Center of Nanjing Military Region General Hospital) were selected. The animals were kept in a ventilated and dry environment with a temperature of (22±1)°C, a relative humidity of 55%-65%, and a 12-h light cycle, and were fed with maintenance diet 1022 for rats and mice.

[0026] 1.2 Reagents and samples

[0027] Boc-L-valine was purchased from China Institute for the Control of Pharmaceutical and Biological Products. Compound (I) is self-made, and the preparation method is shown in Example 1. Rat tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10), enzyme-linked immunosorbent assay (ELISA) detection kits were purchased from Biosource, USA International Company; rat HMGB1 ELISA detection kit was purchased from Japan Shino-Test Company. HMGB1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Boc-L-valine pharmaceutical composition and application in biological pharmacy. The Boc-L-valine pharmaceutical composition is prepared from Boc-L-valine and a natural product compound (I), wherein the natural product compound (I) is of a novel structure and is separated from dry bulbs of lily. The Boc-L-valine and natural product compound (I) composition can remarkably relieve lung injury caused by septicopyemia, has a better effect than that achieved when Boc-L-valine and the natural product compound (I) act alone, can be developed into medicine for treating acute lung injury, and has prominent substantive distinguishing features and a remarkable progress compared with the prior art.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a new application of Boc-L-valine. Background technique [0002] So far, there is no report on the correlation between Boc-L-valine and its pharmaceutical composition and acute lung injury. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical composition of Boc-L-valine, which contains Boc-L-valine and a novel natural product, Boc-L-valine and This natural product can synergistically treat acute lung injury. [0004] Above-mentioned purpose of the present invention is achieved by following technical scheme: [0005] A compound (I) having the following structural formula, [0006] [0007] A pharmaceutical composition of Boc-L-valine, comprising Boc-L-valine, the compound (I) as claimed in claim 1 and a pharmaceutically acceptable carrier, prepared into a required dosage form. [0008] Further, pharmaceutically acceptable carriers i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D493/10A61K31/366A61K31/27A61P11/00
CPCA61K31/27A61K31/366C07D493/10A61K2300/00
Inventor 潘立李义高李小彪赵阳
Owner ZHENJIANG GAOHAI BIOLOGICAL PHARMA CO LTD